
• Vice Chair of the First Professional Committee on Selective Internal Radiation Therapy of the Chinese Anti-Cancer Association
• Member of the China Chapter of the International Hepato-Pancreato-Biliary Association
• Vice Chair of the Professional Committee on Internal Radiation Therapy in Oncology of the China Medical Education Association
• Standing Committee Member of the Liver Cancer Branch of the Guangdong Association of Cancer Rehabilitation
• Former Standing Committee Member of the Professional Committee on Biliary Tract Cancer of the Guangdong Anti-Cancer Association
• Former Standing Committee Member of the Professional Committee on Pancreatic Cancer of the Guangdong Anti-Cancer Association
• Former Standing Committee Member of the Professional Committee on Liver Cancer and Liver Metastases of the Guangdong Clinical Medical Society
• Former Standing Committee Member of the Hepatobiliary Surgery Branch of the Guangdong Medical Doctors Association
• Former Member of the Hepato-Pancreato-Biliary Surgery Branch of the Guangdong Medical Doctors Association
• Former Vice Chair of the Minimally Invasive General Surgery Branch of the Guangdong Medical Doctors Association
One of the first specialists in China to use yttrium-90 to treat liver cancer. In August 2022, Dr. Cao successfully performed South China’s first precision yttrium-90 resin microsphere treatment for liver cancer and led the establishment of a dedicated center for yttrium-90 treatment of liver tumors. He specializes in yttrium-90 microsphere radioembolization for primary liver cancer, intrahepatic cholangiocarcinoma, and liver metastases. Dr. Cao specializes in the diagnosis and treatment of liver tumors, perihilar cholangiocarcinoma (Klatskin tumor), liver cancer, intrahepatic cholangiocarcinoma, liver metastases, pancreatic cancer, malignant hepatobiliary and pancreatic tumors, metastatic liver cancer, gallstones, gallbladder polyps, liver cysts, and liver abscesses.